Medincell is committed to creating better medicines for all, focusing on innovative long-acting injectable therapies for mental health conditions, particularly schizophrenia
Medincell is committed to creating better medicines for all, focusing on innovative long-acting injectable therapies for mental health conditions, particularly schizophrenia. Their proprietary BEPO® technology aims to enhance treatment adherence and accessibility.